"Lymphoma, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Descriptor ID |
D016399
|
| MeSH Number(s) |
C04.557.386.480.750 C15.604.515.569.480.750 C20.683.515.761.480.750
|
| Concept/Terms |
Lymphoma, T-Cell- Lymphoma, T-Cell
- Lymphoma, T Cell
- T-Cell Lymphoma
- Lymphomas, T-Cell
- T Cell Lymphoma
- T-Cell Lymphomas
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell".
This graph shows the total number of publications written about "Lymphoma, T-Cell" by people in this website by year, and whether "Lymphoma, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 6 | 0 | 6 |
| 1996 | 3 | 2 | 5 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 4 | 0 | 4 |
| 2000 | 3 | 0 | 3 |
| 2001 | 5 | 2 | 7 |
| 2002 | 6 | 3 | 9 |
| 2003 | 3 | 2 | 5 |
| 2004 | 5 | 1 | 6 |
| 2005 | 4 | 4 | 8 |
| 2006 | 6 | 0 | 6 |
| 2007 | 6 | 0 | 6 |
| 2008 | 5 | 1 | 6 |
| 2009 | 7 | 1 | 8 |
| 2010 | 4 | 1 | 5 |
| 2011 | 7 | 1 | 8 |
| 2012 | 1 | 1 | 2 |
| 2013 | 6 | 1 | 7 |
| 2014 | 5 | 0 | 5 |
| 2015 | 10 | 3 | 13 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 8 | 0 | 8 |
| 2020 | 6 | 0 | 6 |
| 2021 | 2 | 1 | 3 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, T-Cell" by people in Profiles.
-
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 03 28; 143(13):1231-1241.
-
From the archives of MD Anderson Cancer Center: Monomorphic epitheliotropic intestinal T-cell lymphoma: A case with an unusual immunophenotype and discussion of differential diagnosis. Ann Diagn Pathol. 2024 Jun; 70:152293.
-
A US Multicenter Collaborative Study on Outcomes of Hematopoietic Cell Transplantation in Hepatosplenic T-Cell Lymphoma. Transplant Cell Ther. 2024 May; 30(5):516.e1-516.e10.
-
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica. 2024 01 01; 109(1):209-219.
-
Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma. Chin Clin Oncol. 2024 Feb; 13(1):17.
-
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma. BMC Med. 2023 08 30; 21(1):330.
-
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas. Hematol Oncol Clin North Am. 2023 12; 37(6):1107-1124.
-
Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol. 2022 Oct 01; 158(10):1167-1174.
-
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology. 2022 Dec; 54(7):893-899.
-
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 03; 20(3):285-308.